Beta-oxidation is essential for mouse oocyte developmental competence and early embryo development.

Oocyte and embryo metabolism influence developmental outcomes. While carbohydrates and amino acids are known energy sources, lipid metabolism remains understudied. Mitochondrial beta-oxidation generates ATP from fatty acids, a process requiring carnitine and CPT1B. Prior research has shown that lipid metabolism supports cellular functions in other contexts. However, no prior work had resolved the role of beta-oxidation in oocyte maturation or early embryogenesis. That uncertainty drove investigations into whether lipid metabolism contributes to developmental competence. This gap motivated studies of carnitine and CPT1B in oocyte maturation and preimplantation embryos. No prior work had resolved how lipid metabolism interacts with hormonal or growth factor signals. This gap motivated experiments measuring beta-oxidation in response to maturation signals.

The study aimed to determine the role of beta-oxidation in oocyte maturation and embryo development. Researchers focused on CPT1B and carnitine as key regulators of lipid metabolism. They hypothesized that beta-oxidation supports developmental competence. To test this, they measured Cpt1b mRNA levels in cumulus-oocyte complexes. They also assessed beta-oxidation in response to maturation signals. The study sought to clarify whether lipid metabolism is essential for embryo development. They tested the effects of inhibiting or enhancing beta-oxidation. This gap motivated the use of etomoxir and L-carnitine to manipulate lipid metabolism.

The study used murine cumulus-oocyte complexes and preimplantation embryos. Cpt1b mRNA levels were quantified via real-time RT-PCR. Hormonal induction of oocyte maturation was achieved using human chorionic gonadotropin. In vitro maturation was induced with epidermal growth factor and follicle-stimulating hormone. Beta-oxidation was measured by (3)H(2)O production from [(3)H]palmitic acid. Embryo development was assessed after exposure to etomoxir or L-carnitine. The researchers tracked blastocyst formation rates and cleavage stages. They compared outcomes with and without carbohydrate energy sources.

Cpt1b mRNA levels increased during oocyte maturation and in blastocysts. Beta-oxidation rose significantly in response to maturation signals. Etomoxir reduced beta-oxidation and impaired blastocyst development. L-carnitine supplementation increased beta-oxidation and developmental competence. Without carbohydrates, L-carnitine improved 2-cell cleavage rates. These findings suggest that lipid metabolism supports oocyte maturation. The results indicate that carnitine is a critical cofactor for oocyte development. Beta-oxidation appears to be a key energy source during early embryogenesis.

The authors propose that beta-oxidation is essential for oocyte maturation and early embryo development. They suggest that CPT1B and carnitine are key regulators of lipid metabolism in these processes. The findings indicate that lipid metabolism supports developmental competence. The results suggest that carnitine enhances oocyte and embryo viability. The study implies that energy from fatty acids is crucial when carbohydrates are limited. The authors propose that beta-oxidation is a rate-limiting step in embryo development. They suggest that lipid metabolism is a target for improving reproductive outcomes. These conclusions are based on the observed effects of etomoxir and L-carnitine.